Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Palbociclib (Ibrance) in Combination with Irinotecan and Temozolomide in Pediatric Patients with Recurrent or Refractory Solid Tumors

Grant

Awarded By

Total Award Amount

  • 157302.00

    • Direct Costs

  • 121001.00

    • Sponsor Award Id

    • Contributor

  • Elizabeth Alva   Investigator  
  • Emily Johnston   Investigator  
  • Girish Dhall   Investigator  
  • Gregory Friedman M.D.   Principal Investigator  
  • Jamie Aye   Investigator  
  • Kimberly Whelan M.D.   Investigator  
  • Laura Metrock   Investigator